Daniel C. Baumgart
Impact in
- Genetics top 0.1%
- Inflammatory Bowel Disease
- Mesenchymal stem cell research
- Health Informatics top 0.1%
- Artificial Intelligence in Healthcare and Education
Papers in
- Genetics 112
- Inflammatory Bowel Disease 112
-
- Artificial Intelligence in Healthcare and Education 8
- Co-authors
- William J. Sandborn (7 shared papers)Simon R. Carding (8 shared papers)Íngrid Ordás (1 shared paper)Lars Eckmann (1 shared paper)Mark A. Talamini (1 shared paper)Reed Taylor Sutton (4 shared papers)Richard Neil Fedorak (3 shared papers)Karen Ivy Kroeker (8 shared papers)
- Journals
- Journal of Crohn s and Colitis (18 papers)Gastroenterology (16 papers)Inflammatory Bowel Diseases (13 papers)The Lancet (11 papers)The American Journal of Gastroenterology (10 papers)
- Partner nations
- GermanyCanadaUnited States
In The Last Decade
Daniel C. Baumgart
183 papers receiving 19.7k citations
Daniel C. Baumgart's Hit Papers
Peers
Comparison fields: 5 of 187
- Genetics 11.6k
- Health Informatics 649
- Health Information Management 818
- Gastroenterology 468
- Genetics 586
Countries citing papers authored by Daniel C. Baumgart
This map shows the geographic impact of Daniel C. Baumgart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel C. Baumgart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel C. Baumgart more than expected).
Fields of papers citing papers by Daniel C. Baumgart
This network shows the impact of papers produced by Daniel C. Baumgart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel C. Baumgart. The network helps show where Daniel C. Baumgart may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel C. Baumgart, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 189 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | An overview of clinical decision support systems: benefits, risks, and strategies for success Hit paper breakdown → | 2020 | 1849 |
| 2 | Inflammatory bowel disease: cause and immunobiology Hit paper breakdown → | 2007 | 1777 |
| 3 | Ulcerative colitis Hit paper breakdown → | 2012 | 1753 |
| 4 | Crohn's disease Hit paper breakdown → | 2012 | 1745 |
| 5 | Inflammatory bowel disease: clinical aspects and established and evolving therapies Hit paper breakdown → | 2007 | 1572 |
| 6 | ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications Hit paper breakdown → | 2018 | 1416 |
| 7 | Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial Hit paper breakdown → | 2016 | 858 |
| 8 | The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations Hit paper breakdown → | 2009 | 720 |
| 9 | Imaging techniques for assessment of inflammatory bowel disease: Joint ECCO and ESGAR evidence-based consensus guidelines Hit paper breakdown → | 2013 | 536 |
| 10 | 2020 | 441 | |
| 11 | Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn’s Disease Hit paper breakdown → | 2017 | 385 |
| 12 | Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial Hit paper breakdown → | 2014 | 371 |
| 13 | ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 2: IBD scores and general principles and technical aspects Hit paper breakdown → | 2018 | 366 |
| 14 | 2016 | 272 | |
| 15 | Newer Biologic and Small-Molecule Therapies for Inflammatory Bowel Disease Hit paper breakdown → | 2021 | 264 |
| 16 | 2002 | 215 | |
| 17 | 2016 | 204 | |
| 18 | 2016 | 166 | |
| 19 | 2006 | 161 | |
| 20 | 2011 | 159 |
About Daniel C. Baumgart
Daniel C. Baumgart is a scholar working on Genetics, Health Informatics, Public Health, Environmental and Occupational Health, Immunology and Gastroenterology, having authored 189 papers that have together received 20.3k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (112 papers), Pregnancy and Medication Impact (12 papers), Artificial Intelligence in Healthcare and Education (8 papers), Colorectal Cancer Screening and Detection (6 papers), T-cell and B-cell Immunology (5 papers), Anorectal Disease Treatments and Outcomes (5 papers), Electronic Health Records Systems (5 papers) and Iron Metabolism and Disorders (4 papers). The work is most often cited by research in Genetics (11.6k citations), Health Informatics (649 citations), Health Information Management (818 citations), Gastroenterology (468 citations) and Genetics (586 citations). Daniel C. Baumgart has collaborated with scholars based in Germany, Canada and United States. Frequent co-authors include William J. Sandborn, Simon R. Carding, Íngrid Ordás, Lars Eckmann, Mark A. Talamini, Reed Taylor Sutton, Richard Neil Fedorak, Karen Ivy Kroeker, Daniel C Sadowski and Bertram J. Wiedenmann. Their work appears in journals such as Journal of Crohn s and Colitis, Gastroenterology, Inflammatory Bowel Diseases, The Lancet and The American Journal of Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.